Stockreport

FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next [Yahoo! Finance]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF The FDA has finalized its decision to end the shortage of Eli Lilly's GLP-1 products, including tirzepatide, used in weight-loss and diabetes treatments. This decision [Read more]